The Kaleidoscope of Autoimmunity

References

• Leung PSC, Iwayama T, Prindiville T, Chuang DT, Ansari AA, Wynn R, Dickson R, Coppel R, Gershwin ME. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. Hepatology 1992; 15: 367–372
   PubMed Web of Science ®Google Scholar
• van de Water Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, Kaplan M, Gershwin ME. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. Immunology 1992; 146: 89–94
   Web of Science ®Google Scholar
• van der Woude FJ., Rasmussen N, Lobatto S, Wiik A, Pewrmin H, Van Es LA, van der Giessen M, van der Hem GK. The TH: A utoantibodies against neutrophils and mono-cytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425–429
   PubMed Web of Science ®Google Scholar
• Rasussen N, Wiik A, Pewrmin H, Hoier-Madsen M, Borreg-gard N. Detection and clinical implications of anti-neutrophil cytoplasm antibodies. Semin Resp Med 1989; 10: 149–155
   Web of Science ®Google Scholar
• van Venrooij WJ, Hoet RMA, Castrop J, Hageman B, Mat-taj IW, van de Putte LBA. Anti-Ul small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases. J Clin Invest 1990; 86: 2154–2160
   PubMed Web of Science ®Google Scholar
• Hoet RMA, De Weerd P, Klein Gunnewiek J., Koornneef I, van Venrooij Wi. Epitope regions on Ul small nuclear RNA recognized by anti-UlRNA specific autoantibodies. J Clin Invest 1992
   PubMed Web of Science ®Google Scholar
• Hassfeld W, Steiner G, Hartmuth G, Kolarg O, Scherak W, Graninger W, Thumb N, Smolen JS. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 1989; 32: 1515–1520
   PubMedGoogle Scholar
• Steiner G, Hartmuth K, Skriner K, Maurer-Fogy I, Sinski A, Thlamann E, Hassfeld W, Barta A, Smolen JS. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest 1992; 90: 1061–1066
   PubMed Web of Science ®Google Scholar
• Geysen M, Valerio R, Roitt IM. A thyroxine containing pep-tide can induce murine experimental autoimmune thyroiditis. Hutchings PR, Cooke A, Dawe K, Champion BR. J Exp Med 1992; 175: 869
   PubMed Web of Science ®Google Scholar
• Dawe K, Hutchings PR, Cooke A, Champion BR, Cooke A, Roitt IM. Autoantigens in thyroid diseases. Springer Seminars in Immunopathology 1993
   PubMed Web of Science ®Google Scholar
• Tadmor B, Paterman C, Naparstek Y. Embryonal germ-layer antigens: Target for autoimmunity. Lancet 1992; 339: 975–978
   PubMed Web of Science ®Google Scholar
• Naparstek Y, Ben-Yehuda A, Madaio MP. Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice in heparin. Arthritis Rheumatism 1990; 33: 1554–1559
   PubMed Web of Science ®Google Scholar
• Talal N, Garry RF, Schur PH, Alexander S, Dauphinee MJ, Livas IH, Ballester A, Takei M, Dang H. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990; 85: 1866–1871
   PubMed Web of Science ®Google Scholar
• Khamashta MA. ,. Lancet 1991
   Google Scholar
• Asherson RA, Khamashta MA, Ordi-Ros J. The primary antiphospholipid syndrome: major clinical and serological features. Medicine 1989; 68: 366–374
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Canbiesdes J, Fernandez L, Ponce de Leon S. Antiphospholipid antibodies and antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Balt) 1989; 68: 353–365
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles GJ, Ruiz-Arguelles A, Alarcon-segovia D, Drenkard C, Villa A, Cabiedes J, Presno-Bernal M, Deleze M, Ortiz-Lopez R, Vazquez-Prado J. Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies and the antiphospholipid syndrome. J Rheumatol 1991; 18: 552–558
   PubMed Web of Science ®Google Scholar
• Cabral AR, Cabiedes J, Alarcon-Segovia D. Hemolytic anemia related to an IgM autoantibody to phosphatidycholine that binds in vitro to stored and to bromelain-treated erythrocytes. J Autoimmunity 1990; 3: 773–787
   PubMed Web of Science ®Google Scholar
• Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome by passive transfer of anti-cardiolipin antibodies. Proc Nat Acad Sci 1991; 88: 3069–3973
   PubMed Web of Science ®Google Scholar
• Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anti-cardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558–1663
   PubMed Web of Science ®Google Scholar
• Blank M, Krause I, Ben-Bassat M, Shoenfeld Y. Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmunity 1992; 5: 495–509
   PubMed Web of Science ®Google Scholar
• Fishman P, Shoenfeld Y. Cytokines, interleukin-3 and autoimmunity. Isr J Med Sci 1992; 29: 159–164
   Google Scholar
• Fishman P, Bakimer R, Blank M, Sredni D, Djaldetti M, Shoenfeld Y. The putative role of cytokines in the induction of primary anti-phospholipid syndrome. Clin Exp Immunol 1992; 90: 266–270
   PubMed Web of Science ®Google Scholar
• Fishman P, Falach-Vaknine E, Zigelman R, Bakimer R, Sredni B, Djaldetti M, Shoenfeld Y. Prevention of fetal-loss in experimental anti-phospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 1993; 91: 1834–1837
   PubMed Web of Science ®Google Scholar
• Avrameas S. Natural autoantibodies: from “horror autotox-icus” to “ghothi seauton”. Immunol Today 1991; 12: 154–159
   PubMedGoogle Scholar
• Berneman A, Ternynck T, Avrameas S. Natural mouse Igl reacts with self antigens including molecules involved in the immune response. Eur J Immunol 1992; 22: 625–633
   PubMed Web of Science ®Google Scholar
• Watts RA, Ravirajan CT, Staines NA, Isenberg DA. Detection of human and murine public DNA antibody idiotypes in tissues and sera of patients with autoimmune diseases. Clin Exp Immunol 1991; 83: 267
   PubMed Web of Science ®Google Scholar
• Young F, Tucker L, Rubinstein D, Staines NA. Molecular analysis of a germ-line-encoded idiotypic marker of pathogenic human lupus antibodies. J Immunol 1990; 145: 2545
   PubMed Web of Science ®Google Scholar
• Horneff G, Burmester GR, Emmrich F, Kalden JR. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 1991; 34: 129–140
   PubMed Web of Science ®Google Scholar
• Horneff G, Winkler T, Emmrich F, Kalden JR, Burmester GR. Human anti-mouse antibody response induced by antiCD4 monoclonal antibody therapy in patients with rheumatoid arthritis. Clin Immunol Immunopathol 1991; 59: 89–103
   PubMedGoogle Scholar
• Adorini L. The molecular basis of antigen presentation to T lymphocytes: novel possibilities for immunointervention. Intern Rev Immunol 1990; 6: 1–88
   PubMedGoogle Scholar
• Guery JC, Sette A, Leighton J, Dragomir A, Adorini L. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation. J Exp Med 1992; 175: 1345
   PubMed Web of Science ®Google Scholar
• Acha-Orbea H, Mitchell DJ, Timmerman L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L. Limited heterogeneoty of T cell receptors in experimental allergic encephalomyelitis. Cell 1988; 54: 363–273
   PubMedGoogle Scholar
• Herman A, Kappler JW, Marrack P, Pullen HR. AM. Superantigens: Mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9: 745–772
   PubMed Web of Science ®Google Scholar
• Acha-Orbea H, Palmer E. Mls —a retrovirus exploits the immune system. Immunology Today 1991; 12: 356–361
   PubMedGoogle Scholar
• Acha-Orbea H, Shakhov AN, Scarpellino L, Kolb E, Muller V, Vessaz-Shaw A, Fuchs R, Blochlinger K, Rollini P, Billote J, Sarafidou M, MacDonald HR, Diggelman H. Clonal deletion of Vβ14 positive T cell in mammary tumor virus tran-sgenic mice. Nature 1991; 350: 207–211
   PubMed Web of Science ®Google Scholar
• Held W, Shakhov AN, Waanders G, Scarpellino L, Luethy R, Krahenbuhl JP, MacDonald HR, Acha-Orbea H. An exogenous mammary tumor virus with properties of Mls-la (MTV-7). J Exp Med 1992; 175: 1623–1633
   PubMed Web of Science ®Google Scholar
• Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Mewd 1992; 326: 107–116
   PubMed Web of Science ®Google Scholar
• Dietrich G, Kazatchkine MD. Normal IgG for therapeutic use (IvIg) contain anti-idiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 1990; 85: 620–625
   PubMed Web of Science ®Google Scholar